R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

VITA Accelerator – celebrating start-up innovation’s spark

On Friday, 3rd February, pharmaphorum travelled to Casa Angelini, Angelini Ventures HQ in Rome – the corporate venture vessel of Angelini Industries – for the inaugural Demo Day

R&D

How pharma can incorporate AI into research

The use of artificial intelligence (AI) in the biopharma industry has the potential to revolutionise drug discovery and development, as well as improve patient care.

R&D

Was the response to monkeypox a success?

The viral disease that infected a number of people across various countries caused significant alarm for its potential to spread rapidly.

R&D

JP Morgan 2023 – Alexandre LeVert

Editor-in-chief Jonah Comstock caught up with Alexandre LeVert, chairman, CEO, and co-founder of Osivax, on the sidelines of JP Morgan in San Francisco at the beginning of January of this year.&nbs

Digital

Will clinical trials be held in the metaverse? Five ways the...

The pronounced success of increased tech adoption in accelerating and streamlining clinical trials over the past few years has opened the floodgates for a slew of new technology and tactics

Digital